Renalytix AI collaborates with AstraZeneca to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases

Press/Media

Period	22 Aug 2020

Media coverage

Title	Renalytix AI collaborates with AstraZeneca to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases
Media name/outlet	PharmaBiz
Country/Territory	India
Date	22/08/20
URL	www.pharmabiz.com/NewsDetails.aspx?aid=130571&sid=2
Persons	Barbara Murphy